Home  /  Solutions  /  Lead Optimization

Closed-Loop Lead Optimization for Small-Molecule Drug Discovery

Synfini designs, makes, tests, and analyzes your compounds in one place. Each cycle’s results feed the next design directly, getting you to better lead candidates, faster and more cost effectively.

Tell us about your target and where your series stands.

What Is a Design – Make – Test – Analyze (DMTA) Cycle?

A DMTA cycle is the four-step loop medicinal chemists use to improve a molecule: design a set of compounds, make them, test them, and analyze the results to decide what to design next.

Lead optimization is a series of these cycles, each one informed by the last.

DesignSynDesignMakeSynRoute + SynBuildTestYour TCP + assaysAnalyzeSynPlan + SynDBThe AgileChemistryFoundry:One team.One data system.Results retrain the models before the next design round

Why the Loop Matters

Synfini’s Agile Chemistry Foundry connects AI-driven design and synthesis planning directly with robotic chemistry, testing, and data. Each experimental result informs the next molecules designed and made, turning DMTA into a continuously learning discovery cycle.

The goal is not simply to run cycles faster. It is to make every cycle smarter, enabling better decision making using experimental learning to explore chemical space, prioritize better compounds, and reduce wasted experimentation. Better molecules, faster.

The Emerging Bottleneck in AI-Driven Lead Optimization

AI has made it possible to design millions of molecules rapidly. But those predictions only become useful when molecules can be made and tested, placing even greater pressure on the most time- and resource-intensive parts of the DMTA cycle.

And designing a promising molecule is not the same as designing one that can be readily synthesized. The real challenge is therefore turning computational ideas into synthesizable compounds and experimental data fast enough to drive the next round of optimization.

Lead optimization takes several cycles. A delay inside one cycle repeats in every cycle that follows.

How Synfini Closes the Loop

The Synfini platform connects AI design, route planning, and automated synthesis and testing in a single workflow, so each step hands its output to the next without leaving the system.

DesignSynDesign

AI-powered design

AI models search chemical space to generate new molecules and score each candidate to optimize several objectives at once, including potency, selectivity, and ADMET properties.

MakeSynRoute + SynBuild

Planned and automated synthesis

SynRoute plans practical synthesis routes that are validated on our robotics. SynBuild carries out automated multistep synthesis: SynJet for microscale high-throughput experimentation, SynJet Pro for medchem scale SAR and AutoSyn for flow-based scale-up.

TestYour TPP and testing workflow

Tested against your profile

Compounds are tested against the target candidate profile and testing workflow agreed at the start of the program, and results return as structured data.

AnalyzeSynPlan + SynDB

Results that retrain the models

Results flow into SynPlan, the shared discovery dashboard, and retrain the design models and enable decision making. SynDB adds reaction and property data so routes and predictions improve with each cycle.

What You Bring and What We Run

A program starts with a hit or early lead series that has SAR data, a defined target candidate profile (TCP), and a testing workflow. From there, Synfini builds program specific workflows in the Agile Chemistry Foundry that runs multi-objective design, synthesis, testing, and model retraining in repeated cycles.

You bring

  • A target and a hit series with SAR data
  • A defined target candidate profile (TCP)
  • Your testing workflow and assay requirements
  • A scientific lead who makes the call at each decision point

Synfini runs

  • Multi-objective design of analogs with SynDesign
  • Route planning and automated synthesis
  • Model retraining after every round of results
  • Shared reporting in SynPlan at every cycle

Step 1A conversation about your target, series, and goals

Step 2A program plan built around your TCP and testing workflow

Step 3Typically four DMTA cycles before a go/no-go decision point

Multi-Parameter Optimization with a Pharma Partner

In a kinase program Synfini applied AI-driven DMTA to optimize a challenging chemical series against a tightly defined multi-parameter target candidate profile. The starting lead series required a 14-step synthesis and needed simultaneous improvements in potency, kinase selectivity, and aqueous solubility.

Synfini achieved four of five target product profile goals in four DMTA cycles, as well as defined novel IP space and matching activity to a competitor candidate in subsequent tier assays.

Results — Best compound by DMTA cycle

ParameterTPPStartCycle 1Cycle 2Cycle 3Cycle 4
Kinase A (pIC50)>87.85.76.87.18.4 ✓
Selectivity A/B (fold)>200405406350
Selectivity A/C (fold)>20063563100500 ✓
Aq. Solubility (μM)>10022226500210 ✓
Synthesis steps<8144354 ✓
4 of 5 TPP goals in 4 cycles  ·  14 → 4 synthesis steps  ·  novel IP space  ·  matches competitor best-in-class

A Discovery Partner, Not a CRO

A contract research organization executes a partner’s plan. Synfini is a discovery partner: we run the full design-make-test-analyze loop in the Agile Chemistry Foundry to improve your productivity and success through better design, data and decision making.

 Typical CRO modelSynfini
Who designs the compoundsThe partner sends the designsYour designs and AI models or Synfini designs with SynDesign, guided by your TCP
Who plans the routesThe CRO, per compound orderSynRoute, connected to automated synthesis, with partner oversight
How results reach designReports passed back between teamsResults retrain the design models in one seamless workflow
Who improves the planThe partner, between ordersSynfini and the partner together, every cycle

Who This Is For

Emerging biotech teams with a target and a hit or early lead series who need medicinal chemistry capacity without building a chemistry organization.

Biotech and pharma R&D teams looking to increase the productivity of existing people and pipelines, expand discovery capacity, or add cutting-edge AI and chemistry automation to modernize their R&D workflows.

Build capability without building infrastructure

Advance a hit or early lead with integrated medicinal chemistry, AI, synthesis, and testing, whether you need a complete discovery capability or additional capacity alongside your existing team.

Increase the productivity of existing teams and pipelines

Expand the number of molecules, experiments, and DMTA cycles your team can pursue, while adding cutting-edge AI and chemistry automation without rebuilding your existing R&D organization.

Generate the data to make better decisions, faster

Accelerate iterative optimization and experimental validation so programs reach critical candidate-selection and go/no-go decisions with stronger data and greater confidence.

Frequently Asked Questions

A DMTA cycle is the four-step loop medicinal chemists use to improve a molecule: design a set of compounds, make them, test them, and analyze the results to decide what to design next. Lead optimization is a series of these cycles, each one informed by the last.

Closed-loop means design, synthesis, testing, and analysis run under one integrated platform. Results from each round feed the next design directly, without a handoff between separate vendors.

Lead optimization improves a hit series until a compound meets the target candidate profile well enough to nominate as a candidate. Chemists adjust chemical structure across repeated DMTA cycles to raise potency and selectivity while improving ADMET properties such as solubility, permeability, metabolic stability and toxicity.

A CRO executes a partner’s plan. A discovery partner like Synfini runs the full design-make-test-analyze loop in-house and brings its own AI design tools, or integrates with partner tools, so the plan improves as the data is generated.

SynDesign models search chemical space to generate new structures and score each one against several objectives at once, including potency, selectivity, and ADMET properties. Chemists set the goals and choose what to make; the models widen and rank the options.

Bring your program challenges, the current state of your hit or lead series. If some of these are still in progress, that is fine. The first conversation is to understand where Synfini can plug into your program and what problems you need to solve.

Tell Us About Your Program

Share your program, the stage of your series, and what is slowing you down. A member of our team will reply within 1 business day.

Prefer email? info@synfini.com